PhenoModifier-Variant Detail

Variant "BRCA1:c.115T>G(p.Cys39Gly)"

Search result: 1 record

Variant information

Gene:

BRCA1

Variant:

BRCA1:c.115T>G(p.Cys39Gly)

Genomic location:

chr17:41267762(hg19)

HGVS:

SO Term	RefSeq
protein_coding	NM_007300.3:c.115T>G(p.Cys39Gly)
protein_coding	NM_007298.3:c.115T>G(p.Cys39Gly)
protein_coding	NM_007299.3:c.115T>G(p.Cys39Gly)
protein_coding	NM_007294.3:c.115T>G(p.Cys39Gly)
protein_coding	NM_007297.3:c.-8+8272T>G
pseudogene	NR_027676.1:n.276T>G
show all

dbSNP ID:

rs80357164

GWAS trait:

no data

Modifier statisitcs

Record:

1

Disorder:

1

Reference:

1

Effect type:

Expressivity(1)

Modifier effect:

Risk factor(1)

Detail：

Target disease:

Breast Cancer (DOID_1612)

Effect type:

Expressivity

Modifier effect:

Risk factor

Evidence:

OR=12.2, 95% CI: 1.53; 98.1

Effect:

The BRCA1 Cys39Gly and CYP17A1 -34T>C genetic variations were associated with breast cancer risk.

Reference:

PMID29510000

Title:

Genetic Variations, Exposure to Persistent Organic Pollutants and Breast Cancer Risk - A Greenlandic Case-Control Study.

Species studied:

Human

Abstract:

This study investigated the effects of single nucleotide polymorphisms (SNPs) in xenobiotic and steroid hormone-metabolizing genes in relation to breast cancer risk and explored possible effect modifications on persistent organic pollutants (POPs) and breast cancer associations. The study also assessed effects of Greenlandic BRCA1 founder mutations. Greenlandic Inuit women (77 cases and 84 controls) were included. We determined two founder mutations in BRCA1: Cys39Gly (rs80357164) and 4684delCC, and five SNPs in xenobiotic and oestrogen-metabolizing genes: CYP17A1 -34T>C (rs743572), CYP19A1 *19C>T (rs10046), CYP1A1 Ile462Val (rs1048943), CYP1B Leu432Val (rs1056836) and COMT Val158Met (rs4680). We used chi-square test for comparison of categorical variables between groups. Odds ratio (OR) estimates with 95% confidence interval (95%CI) were obtained using logistic regression models. The variant allele of BRCA1 Cys39Gly increased breast cancer risk (Gly/Cys versus Cys/Cys, OR: 12.2, 95%CI: 1.53; 98.1), and carriers of the variant allele of CYP17A1 -34T>C had reduced risk (CT+CC versus TT, OR: 0.44, 95%CI: 0.21; 0.93). CYP17A1 -34T>C was an effect modifier on the association between perfluoroalkyl acids (PFAAs) and breast cancer risk (∑PFAA, ratio of OR: 0.18, 95%CI: 0.03; 0.97). Non-significant modifying tendencies were seen for the other SNPs on the effect of polychlorinated biphenyls, organochlorine pesticides and PFAAs. In summary, the BRCA1 Cys39Gly and CYP17A1 -34T>C genetic variations were associated with breast cancer risk. Our results indicate that the evaluated genetic variants modify the effects of POP exposure on breast cancer risk; however, further studies are needed to document the data from the relatively small sample size.